Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions

Oral Diseases

Volumn 6, Issue 1, 2000, Pages 35-39

  Souza, Pea ^a   Mesquita, R A ^a   Gomez, R S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Central giant cell lesion; Immunohistochemistry; Pathology; Peripheral giant cell lesion

Indexed keywords

CYCLINE; KI 67 ANTIGEN; PROTEIN MDM2; PROTEIN P53;

ANTIGEN EXPRESSION; ARTICLE; BONE LESION; CELL PROLIFERATION; CHROMOSOME NOR; CLINICAL ARTICLE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAW DISEASE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033973743     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2000.tb00319.x     Document Type: Article

References (37)

1. Allison RT, Best T (1998).p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med 27: 434-440.
2. Bravo R, Frank R, Blundell PA et al (1987). Cyclin PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517.
3. Choung R, Kaban LB, Kozakewich H et al (1986). Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 44: 708-713.
4. Dierenconck JH, Eijsman JH, Keijzer R et al (1991). Cell-cycle related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am J Pathol 138: 1165-1172.
5. Fakan S, Hernandez-Verdun D (1986). The nucleolus and the nucleolar organizer regions. Biol Cell 56: 186-189.
6. Freitas RA, Araújo VC, Araújo NS (1993). Argyrophilia in nucleolar organizer regions (AgNORs) in adenoid cystic carcinoma and low-grade polymorphus adenocarcinoma of salivary gland. Eur Arch Otorhmolaryngol 250: 213-217.
7. Gerdes J, Lemke H, Baisch H et al (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715.
8. Giansanti JS, Waldron CA (1969). Peripheral giant cell granuloma: review of 720 cases. J Oral Surg 27: 787-791.
9. Goodpasture C, Bloom SE (1975). Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromossoma 53: 37-40.
10. Hall PA, Hart I, Goodlad R et al (1994). Expression of proliferating cell nuclear antigen in non-cycling cells may be induced by growth factors in-vivo. Br J Cancer 70: 244-247.
11. Hall PA, McKee PH, Menage HD et al (1993). High levels of p53 protein in UV irradiated human skin. Oncogene 8: 203-207.
12. Harris AL (1992). p53 expression in human breast cancer. Adv Cancer Res 59: 69-88.
13. Harrison RF, Reynolds GM, Rowlands DC (1993). Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions. J Pathol 171: 115-122.
14. Huang WYF, Coltrera M, Schubert M et al (1994). Histopathologic evaluation of proliferating cell nuclear antigen (PC 10) in oral epithelial hyperplasias and premalignant lesion. Oral Surg Oral Med Oral Pathol 78: 748-754.
15. Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP (1988). Peripheral giant cell granuloma. Clinipathologic study of 224 new cases and review of 956 reported cases. Int J Oral Maxillofac Surg 17: 94-99.
16. Kaur J, Srivastava A, Ralhan R (1996). p53-HSP70 complexes in oral dysplasia and cancer: potential prognostic implications. Oral Oncol, Eur J Cancer 32: 45-49.
17. Lane DP (1992). p53, guardian of the genome. Nature 358: 15-16.
18. Meltzer PS (1994). MDM2 and p53: a question of balance. J Natl Cancer Inst 86: 1266-1267.
19. Mesquita RA, Souza SCOM, Araújo NS (1998). Proliferative activity of peripheral ossifying fibroma and ossifying fibroma. J Oral Pathol & Med 27: 64-68.
20. Mighell A (1995). PCNA and p53. Oral Oncol, Eur J Cancer 31B: 403-404.
21. Mighell AJ, Robinson PA, Hume WJ (1996). PCNA and Ki-67 immunoreactivity in multinucleated cells of giant cell granuloma. J Oral Pathol Med 25: 51-54.
22. Momand J, Zambetti GP, Olson D et al (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
23. Neville BW, Damm DD, Allen CM et al (1995). Oral & Maxillofacial Pathology. Saunders: Philadelphia.
24. Nigro JM, Baker SJ, Preisinger AC et al (1989). Mutations in the p53 gene occur in diverse human tumor types. Nature 342: 705-708.
25. Oliner JD, Kinzler KW, Meltzer PS et al (1992). Amplification of gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
26. O'Malley M, Pogrel MA, Stewart JCB et al (1997). Central giant cell granulomas of the jaws: phenotype and proliferation-associated markers. J Oral Pathol Med 26: 159-163.
27. Ploton D, Menager M, Jeannersson P et al (1986). Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region of the optical level. Histochem J 18: 5-14.
28. Reiferberger G, Liu L, Ichimura K et al (1993). Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739.
29. Sawhney N, Hall PA (1992). Ki67-structure, function, and new antibodies. J Pathol 168: 161-162.
30. Schloti T, Reimer S, Jahns A et al (1997). Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours. J Pathol 182: 54-61.
31. Shi SR, Cote RJ, Taylor CR (1997). Antigen retrieval in immunohistochemistry: past, present, and future. J Histochem Cytochem 45: 327-343.
32. Shivji MKK, Kenny MK, Wood RS (1992). Proliferating cell nuclear antigen (PCNA) is required for DNA excision repair. Cell 69: 1-20.
33. Slootweg PJ (1995). p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 24: 393-397.
34. Soini Y, Kamel D, Paakko P et al (1994). Aberrant accumulation of p53 associates with Ki67 and mitotic counts in benign skin lesions. Br J Dermatol 131: 514-520.
35. van Oijen MGCT, Medema RH, Slootweg PJ et al (1998). Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 110: 24-31.
36. Waldron CA, Shafer WG (1966). The central giant cell reparative granuloma of the jaws: An analysis of 38 cases. Am J Clin Pathol 45: 437-447.
37. Whitaker SB, Vigneswaran N, Budnick SD et al (1993). Giant cell lesions of the jaws: evaluation of nucleolar organizer regions in lesions of varying behavior. J Oral Pathol & Med 22: 402-405.